Albert Invent, an Oakland, CA-based provider of an end-to-end R&D platform accelerates chemical innovation in materials science using AI, raised $22.5M in Series A funding.
The round was led by Coatue, with participation from TCV, Index Ventures, F-Prime, and Homebrew.
The company intends to use the funds to expand the engineering team, enhance the platform’s capabilities, and scale operations.
Led by CEO Nick Talken, Albert Invent provides a cloud-based platform that is designed for chemistry and materials science, empowering scientists across 30+ countries to work better in the lab. By offering digital workflows for entire teams, it unifies experimental data, streamlines complex R&D and regulatory processes, and delivers AI-driven insights.
Key features include:
- Molecular predictions: Generate real-time property and toxicology predictions for drawn chemical structures, outperforming standard industry models.
- Structure search: Identify exact matches or similar structures based on drawn chemicals, utilizing advanced similarity modeling techniques.
- Inverse design: Create formulations to meet specific targets, leveraging comprehensive regulatory intelligence and molecular property predictions.
- Active learning: Test predicted formulas seamlessly within the platform, allowing models to evolve and improve predictions with new data.
- SKU rationalization: Identify similar or duplicate formulations efficiently across organization, streamlining product portfolios.
- Model explainability: Access detailed insights into prediction rationales, including influential ingredients, chemical fingerprints, and parameters, along with overall model accuracy.
The company serves customers like Chemours, Solenis, Keystone Industries, Applied Molecules, Henkel and Nouryon.
FinSMEs
11/12/2024